SEPTEMBER 27, 2021

MAIN EVENT 5:30 - 8:30 PM

SPONSORSHIP

O

PPORTUNITIES

LIVE, IN-PERSON

SPONSORSHIP OPPORTUNITIESPresenting Sponsor: $50,000 Exclusive OpportunityGoods & Services: $4,000*Sponsor benefits and recognition include:• Corporate logo and Presenting Sponsor recognition on all event collateral• Social media promotion, featuring your company on Facebook, Instagram & Twitter• Opportunity to host and display in a premier location in the Innovation Gallery • 24 tickets to attend Innovation Night • 20 tickets to use throughout the 2021/2022 Season (subject to availability)• Two designated individuals will be invited to join the Innovation Night host committee• Invitation for 10 to attend the exclusive Sponsor Party, held at The Lodge at Torrey Pines

Gallery Sponsor: $35,000 Exclusive OpportunityGoods & Services: $3,600*Sponsor benefits of Innovation Night include:• Corporate logo and Innovation Gallery Sponsor recognition on all event collateral• Social media promotion, featuring your company on Facebook, Instagram, & Twitter• Opportunity to host and display in a premier location in the Innovation Gallery • 20 tickets to attend Innovation Night• 20 tickets to use throughout the 2021/2022 Season (subject to availability)• Two designated individuals will be invited to join the Innovation Night host committee• Invitation for 10 to attend the exclusive Sponsor Party, held at The Lodge at Torrey Pines.

Lead Sponsor: $25,000Goods & Services: $3,000*Sponsor benefits and recognition include:• Corporate logo and Lead Sponsor recognition on all event collateral• Social media promotion, featuring your company on Facebook, Instagram & Twitter• Opportunity for a deluxe display in the Innovation Gallery at the event (500 impressions)• 20 tickets to attend Innovation Night • 12 tickets to use throughout the 2021/2022 Season (subject to availability)• One designated individual will be invited to join the Innovation Night host committee• Invitation for 8 to attend the exclusive Sponsor Party, held at The Lodge at Torrey Pines

Host Sponsor: $15,000Goods & Services: $2,350*Sponsor benefits and recognition include:• Corporate logo and Host Sponsor recognition on all event collateral• Opportunity for a premium display in the Innovation Gallery at the event (500 impressions)• 16 tickets to attend Innovation Night • 10 tickets to use throughout the 2021/2022 Season (subject to availability)• One designated individual will be invited to join the Innovation Night host committee• Invitation for 6 to attend the exclusive Sponsor Party, held at The Lodge at Torrey Pines

Co-Host Sponsor: $7,500Goods & Services: $1,300*Sponsor benefits and recognition include:• Corporate logo and Co-Host Sponsor recognition on all event collateral• Opportunity for a premium display in the Innovation Gallery at the event (500 impressions)• 10 tickets to attend Innovation Night • 4 tickets to use throughout the 2021/2022 Season (subject to availability)• One designated individual will be invited to join the Innovation Night host committee• Invitation for 4 to attend the exclusive Sponsor Party, held at The Lodge at Torrey Pines

*Fair Market Values: Innovation Night Package = $100/per unit; 2021/2022 Season ticket = $75/per unit; Social Media Promotion = $100

In addition to the benefits and visibility

at Innovation Night on September 27, 2021, all

corporate sponsors will enjoy Corporate Circle benefits throughout

the 2021/2022 Season, including:

• Logo recognition on the Potiker Theatre Corporate Sponsors signage (100,000+ impressions)

• Logo included in all three theatre programs on the Corporate Sponsors page (100,000+ impressions)

• Logo and link on the Corporate Sponsors page of LaJollaPlayhouse.org

• 20% corporate discount on tickets for La Jolla Playhouse productions

• Opportunity to host a pre-show event for your guests in one of our spaces (additional fees and restrictions apply)

WHY INNOVATION NIGHTAs a leader in innovation onstage, La Jolla Playhouse couldn’t be a better place to host this extraordinary event each year, bringing San Diego’s flourishing community of science and technology innovators together for an evening of creative exchange. Over the last twelve years, Innovation Night has raised well over $2 million to help enhance the Playhouse’s own “R&D” efforts — including our signature play development programs, Without Walls (WOW) series of immersive and site-inspired theatre, as well as ongoing artist commissions and residencies — all while facilitating partnerships among artists and leaders in San Diego’s life sciences, biotech, high-tech, clean-tech and defense and telecommunication industries.

IMPORTANT DETAILSMonday, September 27, 2021 at La Jolla Playhouse5:30pm - 8:30pm Elegant cocktail reception for 500 C-level executives and guests with delicious cuisine and open bar. Plus, an Innovation Gallery featuring interactive exhibits from San Diego’s most innovative companies and special performances by String Theory throughout the evening.

List as of September 20, 2021

2021 INNOVATION NIGHT LEADERSHIPChair: Tim Scott, CEO, TEGA TherapeuticsHost Committee:Gordon Alton, CEO and President, Agragene Inc.Denise Bevers, Chief Operating Officer, DTx PharmaCharles Black, Managing Director, J.P. Morgan Private BankJim Breitmeyer, M.D., Ph.D., President and CEO, Oncternal

Therapeutics Inc.Carin Canale-Theakston, Chief Executive Officer,

CanaleCommJennifer Cayer, Chief Business Officer, Pulmocide LimitedAnna E. Diaz, Principal, Lead Advisor, Dowling & Yahnke

Wealth AdvisorsLeo Divinsky, Managing Director of Asset Management,

Stockdale Capital Partners, LLCBrian Dovey, Partner, Domain AssociatesSusan Dubé, Founder and CFO of Sorriso Pharmaceuticals,

Inc.John Dunn, General Counsel and Corporate Secretary,

Vital Therapies Inc.Stephen C. Ferruolo, Partner, Perkins Coie LLPPatrick Frias, M.D., President & Chief Executive Officer, Rady

Children’s Hospital and Health Center-San DiegoJeff Friedman, Managing Partner, Friedman BioventureWendy Gillespie, CEO, Starhawk ProductionsGerardo Godinez, Partner in Charge, Moss AdamsClark Guy, Managing Director, Market Executive,

Bank of America Private BankSusie Harborth, EVP Business Operations Breakthrough

PropertiesGreg Horowitt, Co-Founder & Managing Director, T2

Venture CapitalVyomesh Joshi, CEO & President, 3D SystemsBob Kain, Co-Founder and Chairman, Luna DNA

Bryan Knox, General Manager, CatalentMike Krenn, CEO, ConnectJames MacKay, CEO, Aristea TherapeuticsStanley Maloy, Associate Vice President for Research &

Innovation, San Diego State UniversityMagda Marquet, Founder and Co-Chair, AltheaChris Montgomery, SVP, Business Development, CooleyJulie Stone Moran, San Diego Office Marketplace Leader,

DeloitteTom Murphy, Senior Vice President, Bench InternationalMike Nall, President and CEO, BioceptJoe Panetta, CEO & President, BiocomBernard Parker, Managing Director, Caligen BioRichard W. Pascoe, President and CEO, Histogen, Inc.Robert Price, Managing Director, TI ManagementChristopher A. and Sharon Lee Rhodes, Baywind

BioventuresDon Rosenberg, Executive Vice President, General Counsel

and Corporate Strategy, QualcommIvor Royston, President and CEO, ViractaDrew Senyei, Managing Director, Enterprise Partners

Venture CapitalNatalie Sherod, Risk Advisor, CavignacLarry Stambaugh, Principal, Apercu PartnersAndy Thomas, Senior Vice President Business

Development, Bahia Resort HotelKelly Thomson, Regional Managing Director, Ascent

Private Capital Management of U.S. BankMary Walshok, Associate Vice Chancellor for Public

Programs, UC San DiegoDavid Webb, Adjunct Professor/CEO, Scripps Research

Institute/Synbal Inc.Lorelei Westin, Member, Wilson Sonsini Goodrich & Rosati

LEAD SPONSORS

HOST SPONSORS

CO-HOST SPONSORS

IN-KIND SPONSORS

LIVE, IN-PERSON

ABOUT LA JOLLA PLAYHOUSEWith 33 Broadway transfers, 105 world premieres and a Tony Award for The Rich Family Artistic Director, Christopher Ashley, La Jolla Playhouse is where artists and audiences come together to create what’s new and next in American Theatre.It is our mission to advance theatre as an art form and as a vital social, moral and political platform by providing unfettered creative opportunities for the leading artists of today and tomorrow. With our youthful spirit and eclectic, artist-driven approach we will continue to cultivate a local and national following with an insatiable appetite for audacious and diverse work.

HONORARY CHAIR David F. Hale

LaJollaPlayhouse.org/innovation-night

David Hale is Chairman and CEO of Hale BioPharma Ventures, LLC a private company focused on the formation and development of biotechnology, specialty pharma, diagnostic and medical device companies. Mr. Hale is a serial entrepreneur who has been involved in the formation and development of a number of successful biomedical companies. He served as Chairman of Santarus, Inc., prior

to its sale to Salix Pharmaceuticals, Inc. in 2014, SkinMedica, Inc., prior to its sale to Allergan in 2012, Micromet, Inc., prior to its sale to Amgen Inc. in 2012, Somaxon Pharmaceuticals, prior to its sale to Pernix in 2013, Crisi Medical Systems, prior to its sale to Becton-Dickinson in 2015, and Agility Clinical, prior to its sale to Precision Medicine in 2017.

In 1982, after joining Hybritech, Inc., the first biotechnology company in San Diego, he served as COO, President and then CEO, when Hybritech was acquired by Eli Lilly and Co. in 1986. From 1987 to 1997, he was Chairman, President and CEO of Gensia, Inc., which merged with SICOR to become Gensia Sicor, Inc., which was acquired by Teva Pharmaceuticals. He was a co-founder and Chairman of Viagene, Inc. from 1987 to 1995, when Viagene was acquired by Chiron, Inc. In 1997, he was a co-founder and served as Chairman of LMA North America until its merger with LMA International in 2004.

He joined CancerVax in October 2000, where he served as President and CEO from 2000 until its merger with Micromet, Inc, in 2006, when he became Chairman.

He currently serves on the board of two public companies, Oncternal Therapeutics, Inc., as Chairman, and BIOCEPT, Inc. He also serves on the Board of Directors of private companies Zerigo Health, Inc., Recros Medica, Inc., and Adigica Health, Inc. He is a co-founder and Chairman of Neurana Pharmaceuticals, Inc., a co-founder and Director of Neurelis, Inc., a co-founder and Managing Member of Dermata Therapeutics, Inc., and a co-founder of Cadence, Evoke, Elevation and Zogenix.

Prior to joining Hybritech, Hale was Vice President and General Manager of BBL Microbiology Systems, a division of Becton, Dickinson & Co. and from 1971 to 1980, held various marketing and sales management positions with Ortho Pharmaceutical Corporation, a division of Johnson & Johnson, Inc.

Mr. Hale is a co-founder and serves on the Board of Directors of BIOCOM and CONNECT and is a former member of the Board of the Biotechnology Industry Organization (BIO), and the Biotechnology Institute. He has served on the Board of Rady Children’s Hospital since 1986, including Chairman of the Board from 2011 to 2015, and is founder and Chairman of the Rady Children’s Institute of Genomic Medicine. He serves on the University of San Diego Board of Trustees, is a member of the UCSD Rady School of Management Dean’s Advisory Council, and a Director of the San Diego Economic Development Corporation.

For more information, please contact Sam Watkins, Corporate Relations ManagerEmail: swatkins@ljp.org | Phone: (858) 228-3078Mail: La Jolla Playhouse, PO Box 12039, La Jolla, CA 92039